SCHEMBL31200293

SCHEMBL31200293

O=C1NCc2c(F)cc(C[C@H]3CC[C@H](C(=O)O)CC3)cc21

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 7/20 0.35
PIK3CB P42338 7/20 0.35
PIK3CA P42336 6/20 0.35
PIK3CG P48736 4/20 0.35
TAS2R14 Q9NYV8 3/20 0.34
VCP P55072 2/20 0.34
PLG P00747 1/20 0.34
PLAT P00750 1/20 0.34
LMNA P02545 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPK14 Q16539 1/20 0.34
PTPN1 P18031 2/20 0.33
GRM2 Q14416 1/20 0.33
SELL P14151 1/20 0.33
SELP P16109 1/20 0.33
SELE P16581 1/20 0.33
PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31200346 0.87 HPGD (0.36) PIK3CDPIK3CBPIK3CAPIK3CG
SCHEMBL31200245 0.80 NTRK2 (0.43) TAS2R14VCPPLGPLATLMNA
SCHEMBL31200240 0.80 NTRK2 (0.43) TAS2R14VCPPLGPLATLMNA
SCHEMBL15422809 0.79 PLG (0.43) TAS2R14VCPPLGPLATLMNA
SCHEMBL31200145 0.76 RIPK1 (0.35) PIK3CDPIK3CBPIK3CAPIK3CGGRM2
SCHEMBL30349290 0.76 GRM2 (0.35) PIK3CDPIK3CBPIK3CAPIK3CGGRM2
SCHEMBL27085852 0.74 GRM2 (0.44) PIK3CDPIK3CBPIK3CAPIK3CGGRM2
SCHEMBL31200244 0.70 PLG (0.40) TAS2R14VCPPLGPLATLMNA
SCHEMBL31200363 0.69 TRPM8 (0.39) TAS2R14VCPPLGPLATLMNA
SCHEMBL31200225 0.68 PLG (0.38) TAS2R14VCPPLGPLATLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709722-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2026-03-18 EP disclosed
WO-2024233547-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2024-11-14 WO disclosed